ZNTL
NASDAQ · Biotechnology
Zentalis Pharmaceuticals Inc
$1.82
-0.07 (-3.70%)
Open$1.86
Previous Close$1.89
Day High$1.91
Day Low$1.80
52W High$6.95
52W Low$1.21
Volume—
Avg Volume1.38M
Market Cap179.04M
P/E Ratio—
EPS$-1.91
SectorBiotechnology
Analyst Ratings
Buy
16 analysts
Price Target
+1,388.5% upside
Current
$1.82
$1.82
Target
$27.09
$27.09
$17.95
$27.09 avg
$27.14
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 72.61M | 27.61M | 25.42M |
| Net Income | -178,578,310 | -2,223,610 | -1,538,415 |
| Profit Margin | -246.0% | -8.1% | -6.1% |
| EBITDA | -204,495,165 | -3,072,165 | -2,609,903 |
| Free Cash Flow | — | -1,433,660 | -1,157,693 |
| Rev Growth | — | +21.3% | +16.0% |
| Debt/Equity | — | 0.13 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |